Log In
Print
BCIQ
Print
Print this Print this
 

Breast cancer vaccine (PEV6)

  Manage Alerts
Collapse Summary General Information
Company Pevion Biotech AG
DescriptionVirosome-based breast cancer vaccine using synthetic epidermal growth factor (EGF) receptor 2 (HER2; ErbB2; neu) antigens
Molecular Target Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationBreast cancer
Indication DetailsPrevent tumor recurrence in breast cancer patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today